References
- Gibbs RB. Estrogen therapy and cognition: a review of the cholinergic hypothesis. Endocr Rev 2010;31:224–53.
- Avizheh S, Akbari M, Fatahi J, Pourbakht A, Jalaie S, Sheikholeslami K. Auditory brainstem responses during menstrual cycle and pregnancy. Aud Vest Res 2015;24:217–23.
- Kilicdag EB, Yavuz H, Bagis T, Tarim E, Erkan AN, Kazanci F. Effects of estrogen therapy on hearing in postmenopausal women. Am J Obstet Gynecol 2004;190:77–82.
- Rocca WA, Grossardt BR, Shusterd LT. Oophorectomy, estrogen, and dementia: a 2014 update. Mol Cell Endocrinol 2014;389:7–12.
- Coleman JR, Campbell D, Cooper WA, Welsh MG, Moyer J. Auditory brainstem responses after ovariectomy and estrogen replacement in rat. Hear Res 1994;80:209–15.
- Hederstierna C, Hultcrantz M, Rosenhall U. Estrogen and hearing from a clinical point of view; characteristics of auditory function in women with Turner syndrome. Hear Res 2009;252:3–8.
- Thompson SK, Zhu XX, Frisina DR. Estrogen blockade reduces auditory feedback in CBA mice. Otolaryngol Head Neck Surg 2006;135:100–5.
- Oghan F, Coksuer H. Comparative audiometric evaluation of hearing loss between the premenopausal and postmenopausal period in young women. Am J Otolaryngol 2012;33:322–5.
- Svedbrant J, Bark R, Hultcrantz M, Hederstierna C. Hearing decline in menopausal women-a 10-year follow-up. Acta Otolaryngol 2015;135:807–13.
- Hederstierna C, Hultcrantz M, Rosenhall U. A longitudinal study of hearing decline in women with Turner syndrome. Acta Otolaryngol 2009;27:1–8.
- Jenkins V, Low R, Mitra S. Hearing sensitivity in women following chemotherapy treatment for breast cancer: results from a pilot study. Breast 2009;18:279–83.
- Meltser I, Tahera Y, Simpson E, Hultcrantz M, Charitidi K, Gustafsson JA, Canlon B. Estrogen receptor beta protects against acoustic trauma in mice. J Clin Invest 2008;118:1563–70.
- Pillai JA, Siegel JH. Interaction of Tamoxifen and noise-induced damage to the cochlea. Hear Res 2011;282:161–6.
- Fasunla AJ, Harbeck N, Schmalfeld B, Berktold S, Bohner C, Hundt W, Wolf F, Steinbach S. Is routine audiometric evaluation necessary in gynaecologic tumour patients undergoing chemotherapy? Breast Care (Basel) 2013;8:276–81.
- Zuur CL, Simis YJ, Landsdaal PE, Rasch CR, Tange RA, Balm AJ, Dreschler WA. Audiometric patterns in ototoxicity of intra-arterial Cisplatin chemoradiation in patients with locally advanced head and neck cancer. Audiol Neurootol 2006;11:318–30.
- Dammeyer P, Hellberg V, Wallin I, Laurell G, Shoshan M, Ehrsson H, Arnér ES, Kirkegaard M. Cisplatin and oxaliplatin are toxic to cochlear outer hair cells and both target thioredoxin reductase in organ of Corti cultures. Acta Otolaryngol 2014;134:448–54.
- Gorga M, Dierking D, Johnson T, Beauchaine K, Garner C, Neely S. A validation and potential clinical application of multivariate analyses of distortion-product otoacoustic emission data. Ear Hear 2005;26:593–607.
- Hatzopoulos S, Petruccelli J, Laurell G, Avan P, Finesso M, Martini A. Ototoxic effects of cisplatin in a Sprague-Dawley rat animal model as revealed by ABR and transiently evoked otoacoustic emission measurements. Hear Res 2002;170:70–82.
- Wang J, Wang YF, Jiang XW, Mi WJ, Qiu JH. Expression of NeuroD in spiral ganglion neurons following Cisplatin-induced ototoxicity in rats. Chinese J Otol 2012;10:241–5.
- Cameron VA, Autelitano DJ, Evans JJ, Ellmers LJ, Espiner EA, Nicholls MG, Richards AM. Adrenomedullin expression in rat uterus is correlated with plasma estradiol. Am J Physiol Endocrinol Metab 2002;282:E139–46.